相关实验视频

Updated: Apr 30, 2026

Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development

Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development

Published on: March 5, 2017

用基编辑屏幕对原始人类T细胞的抗瘤特征进行映射变异效应

Zachary H Walsh^1,2,3,4, Parin Shah^1,2,3,4, Neeharika Kothapalli¹

¹Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.

Nature biotechnology

|May 23, 2024

概括

使用基因编辑发现T细胞基因中的功能增益突变可以增强细胞免疫疗法. 这些遗传变异改善了T细胞信号传递和癌细胞杀死,为癌症治疗提供了新的途径.

科学领域:

免疫学免疫学免疫学
遗传学是一个遗传学.
生物技术是生物技术.

背景情况:

在T细胞基因中的单核酸变异 (SNV) 可以引起疾病.
这些SNV具有增强癌症免疫疗法的潜力.

研究的目的:

在T细胞基因中识别新的功能增益 (GOF) 和功能丧失 (LOF) 突变.
评估这些突变在细胞癌症免疫疗法的治疗潜力.

主要方法:

大规模的平行基数编辑屏幕被用来生成数千个基因变异.
工程T细胞,包括嵌合抗原受体 (CAR) T细胞,用于测试变体功能.
具有临床意义的特定基因位置是突变生成的目标.

主要成果:

在PIK3CD,PIK3R1,LCK,SOS1,AKT1和RHOA等基因中发现了广泛的GOF和LOF突变.
具有PIK3CD和PIK3R1GOF突变的工程T细胞显示了增强的信号传导,细胞因子生产和癌细胞解离.
PIK3CD GOF突变改善了CD19 CAR T细胞对白血病模型的疗效.

结论:

在T细胞基因中的新型GOF突变可以显著提高细胞免疫疗法的疗效.
基调编辑屏幕对于发现临床相关的基因变异是有效的.
具有特定GOF突变的T细胞的向基因工程是改善癌症治疗的有希望的策略.

更多相关视频

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...